HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsutoshi Goto Selected Research

Infarction (Infarctions)

11/2004Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsutoshi Goto Research Topics

Disease

8Cardiomegaly (Heart Hypertrophy)
06/2006 - 08/2002
7Ganglion Cysts (Ganglion)
09/2017 - 12/2013
7Hypertrophy
06/2006 - 02/2004
6Pulmonary Hypertension
06/2006 - 07/2002
4Hypoxia (Hypoxemia)
02/2008 - 08/2002
3Amblyopia (Lazy Eye)
01/2023 - 01/2014
3Hypertension (High Blood Pressure)
01/2021 - 01/2004
3Hemianopsia (Bitemporal Hemianopsia)
01/2017 - 01/2016
3Atherosclerosis
06/2006 - 11/2004
3Body Weight (Weight, Body)
06/2006 - 08/2002
3Diabetic Retinopathy (Retinopathy, Diabetic)
06/2006 - 11/2004
3Heart Failure
06/2006 - 11/2004
3Fibrosis (Cirrhosis)
11/2004 - 08/2002
2Macular Degeneration (Age-Related Maculopathy)
01/2024 - 01/2018
2Optic Nerve Diseases (Optic Neuropathy)
03/2016 - 01/2015
2Atrophy
01/2015 - 12/2013
2Inflammation (Inflammations)
12/2013 - 10/2002
2Endotoxemia
06/2006 - 06/2006
2Leukostasis
06/2006 - 01/2006
2Blindness (Hysterical Blindness)
06/2006 - 01/2006
2Myocardial Infarction
11/2004 - 11/2004
2Right Ventricular Hypertrophy
11/2004 - 08/2002
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
03/2016
1Stroke (Strokes)
01/2016
1Pupil Disorders (Marcus Gunn Pupil)
01/2015
1Pulmonary Arterial Hypertension
11/2014
1Refractive Errors (Refractive Error)
01/2014
1Optic Neuritis (Retrobulbar Neuritis)
12/2013
1Sleep Deprivation
07/2006
1Reperfusion Injury
06/2006
1Angle-Closure Glaucoma (Glaucoma, Angle Closure)
06/2006
1Sepsis (Septicemia)
06/2006
1Ischemia
06/2006
1Hypotension (Low Blood Pressure)
06/2006
1Acute Lung Injury
06/2006
1Septic Shock (Toxic Shock Syndrome)
06/2006
1Retinal Artery Occlusion
06/2006
1Weight Loss (Weight Reduction)
06/2006
1Narcolepsy
04/2005
1Infarction (Infarctions)
11/2004
1Pulmonary Heart Disease (Cor Pulmonale)
11/2004
1Eye Diseases (Eye Disease)
11/2004
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
02/2004
1Hypertensive Nephropathy
01/2004
1Cardiovascular Diseases (Cardiovascular Disease)
02/2003
1Vascular Remodeling
10/2002
1Pathologic Constriction (Stenosis)
10/2002

Drug/Important Bio-Agent (IBA)

13Endothelin-1 (Endothelin 1)IBA
06/2006 - 08/2002
12Retinaldehyde (Retinal)IBA
09/2017 - 11/2004
9Endothelins (Endothelin)IBA
06/2006 - 07/2002
7Vasoconstrictor AgentsIBA
06/2006 - 11/2004
6Messenger RNA (mRNA)IBA
06/2006 - 08/2002
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2004 - 08/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 01/2006
4Peptides (Polypeptides)IBA
06/2006 - 01/2006
4PPAR alphaIBA
11/2004 - 08/2002
3Fenofibrate (CiL)FDA LinkGeneric
11/2004 - 08/2002
3Brain Natriuretic Peptide (Natrecor)FDA Link
11/2004 - 02/2004
3Endothelin A ReceptorIBA
11/2004 - 07/2002
2OrexinsIBA
07/2006 - 04/2005
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2006 - 01/2006
2MonocrotalineIBA
11/2004 - 08/2002
2salicylhydroxamic acid (SHAM)IBA
11/2004 - 08/2002
2N- (6- methoxy- 5- (2- methoxyphenoxy)- 2- (pyrimidin- 2- yl)pyrimidin- 4- yl)- 2- phenylethenesulfonamide (YM598)IBA
11/2004 - 11/2004
2Bosentan (Tracleer)FDA Link
11/2004 - 02/2003
2Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2003 - 07/2002
2PPAR gammaIBA
08/2002 - 08/2002
1brolucizumabIBA
01/2024
1afliberceptIBA
01/2024
1Ophthalmic Solutions (Eye Drops)IBA
01/2023
1AtropineFDA LinkGeneric
01/2023
1Endothelial Growth FactorsIBA
01/2018
12-toluenesulfonamide (OTS)IBA
01/2017
1Oxygen (Dioxygen)IBA
02/2008
1Proteins (Proteins, Gene)FDA Link
02/2008
1CalciumIBA
07/2006
1Nitric Oxide Synthase (NO Synthase)IBA
06/2006
1NeuropeptidesIBA
04/2005
1Triglycerides (Triacylglycerol)IBA
11/2004
1Protein Kinase CIBA
11/2004
1Fatty Acids (Saturated Fatty Acids)IBA
11/2004
1EnzymesIBA
11/2004
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2004
1Mitogen-Activated Protein KinasesIBA
11/2004
1Phosphotransferases (Kinase)IBA
02/2004
1Ventricular MyosinsIBA
02/2004
1ReninIBA
01/2004
1(1S,2R,3S)- 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)- 4- methoxyphenyl)- 2,3- dihydro- 5- propoxy- 1H-Indene-2-carboxylic acidIBA
01/2004
1AngiotensinogenIBA
01/2004
1Endothelin B ReceptorIBA
10/2002
1A 192621IBA
10/2002
1T 0201IBA
10/2002
1p38 Mitogen-Activated Protein KinasesIBA
10/2002
1DinitrofluorobenzeneIBA
10/2002

Therapy/Procedure

2Injections
01/2024 - 01/2021
2Therapeutics
01/2018 - 11/2014
2Ligation
11/2004 - 10/2002
1Aftercare (After-Treatment)
12/2013
1Caloric Restriction
06/2006
1Subcutaneous Injections
11/2004